N/A N=36 Randomized

Outlook Quality of Life Intervention

Cancer · Congestive Heart Failure · Chronic Obstructive Pulmonary Disease

Bottom Line

View on ClinicalTrials.gov: NCT00784095 ↗

Enrolled (actual)

Serious AEs

2.8%

Results posted

Mar 2016

Primary outcome: Primary: Quality of Life - Preparation — 14.4; 16.0; 15.4; 15.2 units on a scale — p=.047

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Life completion and preparation (Other); Attention Control (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: VA Office of Research and Development
Primary completion: May 2009

Outcome Measures

Outcome	Result	p-value
PRIMARY Quality of Life - Preparation	14.4; 16.0; 15.4; 15.2; 14.8; 14.5	.047 sig
PRIMARY QUAL-E Completion Sub-scale	22.4; 24.5; 22.5; 22.6; 25.3; 23.1	—
SECONDARY Functional Status ADL	22.3; 21.0; 29.7; 23; 24; 30.6	—
SECONDARY Center for Epidemiology Studies - Depression Scale (CES-D)	12.0; 12.0; 13.4; 12.4; 12.6; 12.3	—
SECONDARY POMS Anxiety Sub-scale	5.0; 4.1; 5.3; 5.1; 5.0; 5.9	—

Summary

The purpose of this study is to determine whether discussions of life story, forgiveness, and future goals improve quality of life for patients with serious illness.

Eligibility Criteria

Inclusion Criteria

Patients with advanced cancer, CHF or COPD.

Exclusion Criteria

Cognitive impairment, inability to speak, non-English speaking

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00784095). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.